Specify a stock or a cryptocurrency in the search bar to get a summary
Cochlear Ltd
OC5Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia. Address: 1 University Avenue, Sydney, NSW, Australia, 2109
Analytics
WallStreet Target Price
420.51 AUDP/E ratio
53.2298Dividend Yield
1.44 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures OC5
Dividend Analytics OC5
Dividend growth over 5 years
10 %Continuous growth
3 yearsPayout Ratio 5 years average
45 %Dividend History OC5
Stock Valuation OC5
Financials OC5
Results | 2019 | Dynamics |